Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Vertex reports after market close, meaning Day 0 captures anticipatory moves before results are released, while Day +1 reflects the market's first full session to digest the actual numbers.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-08-03 | +$0.49 (+3.80%) | $0.57 (4.41%) | -$1.01 (-7.54%) | $1.40 (10.49%) |
| 2026-05-07 | +$2.01 (+15.88%) | $1.05 (8.29%) | +$0.26 (+1.77%) | $0.90 (6.13%) |
| 2026-02-11 | -$2.05 (-13.78%) | $3.29 (22.08%) | -$0.46 (-3.59%) | $0.94 (7.37%) |
| 2025-11-03 | -$2.21 (-9.65%) | $3.66 (16.00%) | -$0.78 (-3.77%) | $1.34 (6.48%) |
| 2025-08-06 | -$5.97 (-18.05%) | $2.41 (7.29%) | +$0.39 (+1.44%) | $1.90 (7.03%) |
| 2025-05-07 | -$1.26 (-3.26%) | $2.62 (6.77%) | +$0.08 (+0.21%) | $0.85 (2.27%) |
| 2025-02-27 | -$8.09 (-18.98%) | $8.23 (19.31%) | -$2.25 (-6.51%) | $1.89 (5.47%) |
| 2024-11-06 | +$6.05 (+13.84%) | $5.34 (12.23%) | +$1.57 (+3.16%) | $2.78 (5.59%) |
| Avg Abs Move | 12.15% | 12.05% | 3.50% | 6.35% |
Historical price action around earnings reveals significant volatility, with an average absolute Day 0 move of 12.15% and Day +1 move of 3.50%. The stock has shown a pronounced tendency toward negative reactions, particularly on Day 0, with five of the last eight earnings events producing declines during the anticipation phase.
The most recent Q2 2026 report (August 3) exemplifies this pattern: despite beating estimates, VERX fell 7.54% the following day after a modest 3.80% Day 0 gain. The previous quarter (May 7, 2026) produced the opposite outcome — a massive 15.88% Day 0 surge followed by continued strength. The largest single-day move came on February 27, 2025, when the stock plunged 18.98% on Day 0.
Investors should prepare for substantial price swings. The average Day 0 range of 12.05% and Day +1 range of 6.35% indicate VERX typically experiences wide intraday volatility around earnings, regardless of whether results beat or miss. The recent trend of negative Day +1 reactions — even after beats — suggests the market has been quick to sell the news, making post-earnings positioning particularly challenging.
| Metric | Value |
|---|---|
| Expiration Date | 11/20/26 (DTE 17) |
| Expected Move | $1.93 (12.64%) |
| Expected Range | $13.33 to $17.19 |
| Implied Volatility | 79.14% |
The options market is pricing an expected move of ±12.64% for the November 20 expiration, slightly above the historical average Day 0 move of 12.15% but well above the typical Day +1 move of 3.50%. This suggests options traders are anticipating volatility in line with VERX's recent history, though the 79.14% implied volatility reflects elevated uncertainty heading into the print.
Analysts maintain a cautiously optimistic stance on Vertex, with a consensus rating of 3.81 (between Hold and Buy) and an average price target of $16.77. The current breakdown shows 6 Strong Buy ratings, 1 Moderate Buy, and 9 Hold ratings, with no sell recommendations. Price targets range from a low of $12.00 to a high of $25.00, reflecting significant disagreement about the company's valuation and growth trajectory.
The consensus target of $16.77 implies 9.9% upside from the current price of $15.26, suggesting analysts see modest appreciation potential even after the stock's recent 31% rally. The wide target range — spanning more than 100% from low to high — underscores the uncertainty around VERX's ability to execute on its margin expansion story while maintaining revenue growth.
Analyst sentiment has remained unchanged over the past month, with the same distribution of ratings and a stable average recommendation of 3.81. This stability comes despite recent price target adjustments from firms like DA Davidson (cut to $12) and TD Cowen (cut to $15), suggesting the analyst community is taking a wait-and-see approach rather than making bold calls ahead of earnings. The concentration of Hold ratings (9 of 16 analysts) reflects this cautious posture — most analysts acknowledge VERX's potential but want to see sustained execution before upgrading their stance.
Vertex enters earnings with strong technical momentum, trading at $15.26 and positioned above all six major moving averages — a bullish configuration that reflects the stock's powerful 31% rally over the past month. The Barchart Technical Opinion currently shows a 72% Buy signal, unchanged from last week but representing a dramatic improvement from the 56% Sell signal just one month ago.
Timeframe Analysis:
Trend Characteristics: The trend is characterized as having Soft strength with Average direction, suggesting momentum is building but lacks the conviction of a mature uptrend — the stock is in an improving but still transitional technical phase.
The moving average structure tells a compelling story of trend acceleration. VERX trades 0.3% above its 5-day MA ($15.22), 0.8% above its 10-day MA ($15.14), 7.9% above its 20-day MA ($14.14), 15.3% above its 50-day MA ($13.23), 19.4% above its 100-day MA ($12.78), and 15.2% above its 200-day MA ($13.25). This expanding premium to longer-term averages indicates a stock breaking out of a consolidation phase.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $15.22 | 50-Day MA | $13.23 |
| 10-Day MA | $15.14 | 100-Day MA | $12.78 |
| 20-Day MA | $14.14 | 200-Day MA | $13.25 |
Key resistance likely sits near the $16.17 intraday high from today's session, while support has established around the $15.22-$15.27 zone where the 5-day and 10-day moving averages converge. The 20-day MA at $14.14 represents the first meaningful support level if the stock sells off post-earnings. Overall, the technical setup is supportive heading into the report — the stock has momentum, sits well above key moving averages, and shows improving breadth across all timeframes. However, the "Soft" strength characterization and the stock's history of volatile post-earnings reactions suggest traders should respect the potential for sharp reversals regardless of whether results beat or miss estimates.